ERS Endocrinologie SRL

ERS Endocrinologie reported total assets of 377,249 € at the end of the 2025 financial year (annual accounts filed with the NBB on 04 Aug 2026).

By total assets for 2025, ERS Endocrinologie ranks among the 20,000 largest of the 50,431 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0824.351.233 · VAT BE0824351233
6600 Bastogne
active in Business and other management consultancy activities (NACE 70200)
operating since 26 Mar 2010 (≈ 16 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of ERS Endocrinologie shows with a free account.

See the score
Profile
SRL since 2010
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result65,903 €
Equity345,396 €
Cash272,068 €
EBITDA146,764 €
Total assets377,249 €
The line marks its sector median: 50.1% (9034 companies).

Change 2022 → 2025: Equity +31 % Total assets +31 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

ERS Endocrinologie's annual accounts

20252024202320222021
Net result65,903 €
Equity345,396 €
Cash272,068 €
EBITDA146,764 €
Total assets377,249 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 04 Aug 2026
  • Year ended 31 Dec 2024filed on 11 Aug 2025
  • Year ended 31 Dec 2023filed on 23 Aug 2024
  • Year ended 31 Dec 2022filed on 23 Aug 2023
  • Year ended 31 Dec 2021filed on 23 Sep 2022

ERS Endocrinologie's financial analysis

Management and control of ERS Endocrinologie

1 active director(s) in the register.

ERS Endocrinologie's shareholders and holdings →

ERS Endocrinologie's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0824.351.233
VAT number
BE0824351233
Peppol
Registered · 0208:0824351233 · as of 10 Nov 2026
Legal form
SRL
Incorporated
26 Mar 2010
Registered office
6600 Bastogne
Latest accounts
2025 · filed on 04 Aug 2026
Activity
Business and other management consultancy activities (NACE 70200)

ERS Endocrinologie (SRL) has been based in Bastogne since 2010, active in: business and other management consultancy activities. For 2025, it reports a net profit of 65,903 € and equity of 345,396 €; its revenue is not published. Its solvency stands at 91.6%, above the median of its sector (50.1%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to ERS Endocrinologie

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about ERS Endocrinologie

What is the revenue of ERS Endocrinologie?

ERS Endocrinologie files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of ERS Endocrinologie?

In Belgium, the VAT number is the company number prefixed with BE: BE0824351233 for ERS Endocrinologie, if the company is VAT-registered. Its company number (CBE) is 0824.351.233.

Where is the registered office of ERS Endocrinologie?

According to the CBE register, the registered office of ERS Endocrinologie is in 6600 Bastogne.

What is the equity of ERS Endocrinologie?

At the close of the 2025 financial year, the equity of ERS Endocrinologie amounts to 345,396 €, a solvency of 91.6% of total assets.

Who manages ERS Endocrinologie?

The register lists 1 active mandates at ERS Endocrinologie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is ERS Endocrinologie within its sector?

By total assets for 2025, ERS Endocrinologie ranks among the 20,000 largest of the 50,431 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year.

Idonis

The full file of ERS Endocrinologie

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 26 Aug 2026

No credit card, no commitment.

What each plan unlocks →